TrialThe New England journal of medicine2015
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Michael A Postow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,470 papers cite itlatest 60 shown
this paperpooled ittrialcites it